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Objective. The maximum surgical blood ordering schedule (MSBOS) has reduced but not eliminated the over-ordering and
wastage of blood products. Electronic cross-matching (ECM) may be a suitable alternative method to provide blood on
demand in eligible cases. The purpose of this study was to assess the department’s current blood ordering policy and to identify
patients eligible for ECM.
Study Design. This was a retrospective observational study of 88 consecutive maxillofacial surgical oncology patients.
Results. A total of 383 units of blood were cross-matched, of which 43% were not transfused. Of these, 38% were reallocated
and 5% discarded. Of all cross-matched blood, 82% was eligible for ECM; 18% was not eligible, 6% because of the presence
of antibodies and 12% because of lack of a second historical sample.
Conclusions. ECM is recommended as a safe method for elective surgery. Blood can be provided on demand, reducing workload
and costs for transfusion services and minimizing wastage. (Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:534-539)BLOOD SUPPLY CONSIDERATIONS
Blood donation is voluntary in the United Kingdom,
with only 4% of the eligible population donating blood
regularly.1 Blood transfusion services are challenged
to maintain a ﬁne balance between the supply of this
limited resource and an increasing demand. Wastage of
blood products due to nonutilization and expiration is
not only expensive but also can produce shortages in
stock levels at times of peak need.2
The maximum surgical blood order schedule (MSBOS)
was designed to aid control of blood bank inventory
stock by improving the efﬁciency of ordering blood for
use in elective surgery.3,4 The MSBOS is a table of
elective surgical procedures that provides the recom-
mended number of units of blood to be cross-matched.5*This study was presented as an oral presentation in the British
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534The ﬁgures are derived from local analyses of the
amount of blood transfused during individual surgical
procedures. It aims for blood to be ordered and reserved
for patients scheduled for surgical procedures according
to a locally-agreed tariff of expected blood usage.5 This
practice has helped to decrease, but unfortunately has not
eliminated, unnecessary preoperative cross-matching
resulting in over-ordering of blood.6
The British Committee for Standards in Haematol-
ogy (BCSH) has produced guidelines for pretransfusion
compatibility testing to ensure quality and safety in
blood transfusion.7,8 Compatibility testing involves 4
stages: a review of the patient’s transfusion history,
ABO and Rh grouping, antibody screening, and the
cross-match itself.9,10 The degree of importance of each
stage for determining compatibility has changed over
the last decade, with a shift in focus from the serologic
cross-match to the antibody screen.9,10
Cross-matching methods available
Full cross-matching involves a number of techniques to
exclude incompatibility between recipient and donor.Statement of Clinical Relevance
Electronic cross-matching could be used as a method
to provide blood within minutes of request and to
avoid unnecessary preoperative cross-matching in
eligible cases, thus reducing work and costs for
transfusion services and minimizing wastage from
expiration of blood products.
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patient’s serum is incubated with red cells from the
donor unit intended for transfusion. The indirect anti-
globulin test takes approximately 20 to 30 minutes and
in the past was required for every unit of donor blood
to be transfused.11 Blood units that are conventionally
cross-matched by this method preoperatively are allo-
cated and reserved solely for the patient and cannot be
accessed for use in other patients until the post-
operative period, by which time units are less fresh and
may have expired.
In recent years it has been shown that patients with
a negative antibody screen and no historical record of
cell antibodies do not require the full conventional
cross-match test.12 Instead, a group-and-save technique
(G&S, type and screen) can be used, and this has been
widely adopted for surgical procedures for which the
MSBOS shows that blood is rarely transfused.12 The
G&S includes blood grouping, an antibody screen, and
saving. If the antibody screen is positive, then a full
cross-match is required; however, if the antibody screen
is negative, the antiglobulin phase of the cross-match
can be omitted.10,12 These patients can safely have any
ABO- and Rh-compatible blood “off the shelf” if
transfusion is required, with the compatibility of the
donor unit conﬁrmed rapidly on demand by an abbre-
viated cross-match test.9
There are 2 methods for abbreviated cross-match
testing: the immediate spin cross-match (ISCM) and
the electronic cross-match (ECM, also known as
computer CM).
ISCM detects major ABO incompatibility between
donor and recipient by incubation of patient serum
and donor red cells for 5 minutes at room temperature.
ABO compatibility is indicated by the absence of
agglutination. ISCM makes blood available to patients
faster and is more cost-effective than the conventional
cross-match technique, but it does not always detect
ABO incompatibility, and there is no standardized
procedure for its use.8-10,13
ECM is an alternative abbreviated cross-match per-
formed by computer veriﬁcation of ABO/Rh compati-
bility of donor and recipient without any serologic
testing.8-10,13 Using a validated computer system and bar
code readers, a program analyzes the ABO of the patient,
conﬁrming the results of a current sample versus histor-
ical results.8,9 The selected donor unit’s individual bar
code is scanned, and if compatibility is veriﬁed, a label
will be printed, allowing assignment to the patient. ECM
also enables the potential for remote issue of blood
release outside the laboratory, which can further shorten
the turnaround. One example of this is in a center in
Hong Kong that established a self-service electronic issue
system with operating room refrigerators performing as
vending machines to increase the turnaround time.14Requirements of the ECM include: (1) two corre-
sponding results of the patient’s ABO/Rh status must be
on record, one from the current sample and the other
from a historical sample; (2) no clinically signiﬁcant
antibodies can be detected in the patient’s serum, either
from the current sample or historically; (3) the
computer system and all critical elements of the ECM,
such as bar code readers, must be validated on-site; (4)
procedures must be in place to verify that the data
entered are correct before the release of blood units; and
(5) the system must prevent the release or assignment of
ABO-incompatible blood. 9,10,13,15
The disadvantages of ECM include its failure to detect
weak antibodies and the need for extensive computer
validation, employee training, and competency testing.
Potential and unexpected computer downtime is also
a risk, and thus a manual backup contingency system
is critical.10 In addition to its rapid turnaround time,
ECM’s advantages include reduced laboratory workload,
lower reagent costs, more reliability in detection of
ABO-incompatible units, improved quality control, and
reduced expiration and wastage of blood units.9
ECM is currently used in the United Kingdom, Ireland,
France, Denmark, Italy, Sweden, North America, Hong
Kong, Japan, New Zealand, and Australia.16 There are 2
sets of guidelines published for ECM, one from the
American Association of Blood Banks and the other from
the Blood Transfusion Task Force of the BCSH, which
are used in their respective countries of origin.9,10,15 The
BCSH guidelines, in contrast to those of the American
Association of Blood Banks, do not require the ABO of
the donor blood to be serologically conﬁrmed once it
has been labeled, instead accepting the guarantee of its
accuracy from the blood supplier. The BCSH guidelines
also require that historical results are not displayed on
screen if current test results are entered manually.15Objectives of previous studies and the present
study
Previous studies have investigated models for predict-
ing transfusion requirements in their respective surgical
disciplines.17-20 These studies have looked at individual
patient variables to estimate more accurately a patient’s
transfusion requirements, but they have only provided
a guide to blood ordering, failing to indicate how more
blood could be ordered quickly and efﬁciently if there
were a need for further transfusions to cover unex-
pected extensive tumor spread or intraoperative or
postoperative complications.18,21-23
The main aim of this study was to supplement
previous research and propose ECM as a method to
ensure rapid and effective ordering of blood, which
will, at the same time, help reduce any over-ordering
and wastage of nonutilized blood. This study was
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cross-matched to the actual numbers transfused during
elective maxillofacial oncology surgery. It set out to
assess whether it was possible to reduce the number of
units of blood unnecessarily cross-matched and to
determine the safety and practicality of replacing the
preoperative cross-match with a G&S-only policy for
all head and neck cancer surgery patients.MATERIALS AND METHODS
This retrospective studywas undertaken at theUniversity
Hospital of Wales, Cardiff. Before its start, agreement
was obtained from the hospital’s Clinical Governance
Department. The study included all patients who
received elective maxillofacial oncology surgery at the
University Hospital of Wales over a 12-month period.
Data were collected from the patients’ medical records
and anesthetic charts and from the hematology and blood
transfusion laboratory computer database. Any patients
who required emergency surgery or received transfusion
preoperatively were excluded.
Computerized data were recorded relating to age;
gender; pre- and postoperative hemoglobin concentra-
tions; pre- and postoperative blood requirements,
including those cross-matched, transfused, and returned
to the blood bank; and type of surgery. The database
was checked for accuracy by different observers and
has been successfully used in previous studies.22,23
All patients had postoperative blood checks. The
hemoglobin threshold for transfusion for these patients
was set at 80 g/L according to a locally agreed protocol.
Blood utilization in elective operative procedures can
be evaluated using various indices, such as the cross-
match to transfusion ratio (C:T) and the transfusion
index (TI).5
These indices were calculated using the following
formulas:
C : T ratio ¼ No: of units cross-matchedNo: of units transfused
TI ¼ No: of units transfusedNo: of patients cross-matched
RESULTS
A total of 88 consecutive maxillofacial oncology
patients who underwent major surgery (52 male and 36
female patients) were investigated. All data values were
available and complete for all patients. The surgical
procedures included neck dissection (n ¼ 7); excision of
tumor and neck dissection (n ¼ 13); excision of tumor,
neck dissection, and free ﬂap (n ¼ 49); and excision of
tumor, neck dissection, and pedicle ﬂap (n ¼ 19). The
two procedures involving ﬂap reconstruction required
composite resection (commando procedure) to achieve
clear surgical margins (n ¼ 68).Themean preoperative hemoglobin level was 129 g/L;
levels for both male and female patients were within
the normal range. The mean 48-hour postoperative
hemoglobin level was 97 g/L (range, 60-148 g/L).
Blood transfusion was required for 57 patients intra-
operatively to replace blood lost to hemorrhage. A total of
16 patients were transfused postoperatively with a mean
hemoglobin level of 70 g/L (range, 60-77 g/L), below the
locally agreed hemoglobin threshold for transfusion of
80 g/L. Of these patients, 9 were transfused 1 day post-
operatively, 6 were transfused 2 days postoperatively,
and one was transfused 3 days postoperatively.
Table I shows the surgical procedures undertaken,
the number of units of preoperative cross-matched
blood, the number of patients transfused, the number
of units transfused, the C:T ratio, and the TI. Ideally
the C:T ratio would be 1.0; any higher value means
that more blood is being cross-matched than is being
used.5 It has been suggested that a C:T ratio up to 2.5
is more practical.24,25 A C:T ratio over 2.5 would
suggest that under 40% of cross-matched blood is
being transfused, an indication that blood is being
cross-matched excessively.24-26
The TI reveals the average number of units cross-
matched per procedure. A TI of 0.5 or greater suggests
efﬁcient usage of blood.25,27,28 The need for transfusion
for each procedure can be inferred from the TI; the
higher the value, the more blood transfused per proce-
dure, and therefore the higher the perceived need for
transfusion. If the TI value is less than 0.5, it suggests
that cross-matching blood is unnecessary and a G&S
policy should be adopted instead.25
The C:T ratio for patients undergoing excision of
tumor, neck dissection, and free ﬂap is 2.6, indicating
over-ordering of blood for this procedure. The TI value
is 2.0, however, which conﬁrms blood is required for
the procedure. The C:T ratios for the neck dissection
alone; excision of tumor and neck dissection; and
excision of tumor, neck dissection, and pedicle ﬂap are
all less than 2.5, suggesting that the correct amount of
blood was being ordered. This is supported by the TI
values for the 3 surgical procedures, which are 1.9, 4.2,
and 2.9, respectively, suggesting efﬁcient usage of
blood. The excision of tumor and neck dissection
procedure has the highest TI value, indicating the
highest need for transfusion.
Out of all the cross-matched blood, the eligibility for
ECM was as follows:
 82% of units were potentially eligible for ECM
 6% had a positive antibody screen and hence were
not eligible for ECM
 12% were not eligible as they had only one sample
taken despite having a negative antibody screen
(no second historical sample was available)
Table I. Head and neck surgical procedures and blood transfusion requirements
Surgical procedure
Number of procedures/
patients cross-matched
(n ¼ 88)
Units of blood
cross-matched
(range per patient)
Number of patients
transfused
Units of blood
transfused C:T ratio TI
Neck dissection 7 15 (2-4) 6 13 1.2 1.9
Excision of tumor and neck
dissection
13 59 (2-6) 11 54 1.1 4.2
Excision of tumor, neck
dissection, and free ﬂap
49 245 (2-6) 37 96 2.6 2.0
Excision of tumor, neck
dissection, and pedicle ﬂap
19 64 (2-6) 19 55 1.2 2.9
Total 88 383 73 218 1.8 2.5
C:T ratio, cross-match to transfusion ratio; TI, transfusion index.
Table II. The total amount of blood requested, trans-
fused, reallocated, and discarded, in units
RBCs FFP Platelets Cryoprecipitate Total (%)
Requested 353 25 3 2 383
Transfused 192 21 3 2 218 (57)
Reallocated 147 0 0 0 147 (38)
Discarded 14 4 0 0 18 (5)
RBCs, red blood cells; FFP, fresh frozen plasma.
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matched in 12 months for the 88 patients totalled 383
units. The total amount of cross-matched units for each
blood component requested over the 12-month period is
demonstrated in Table II.
The total number of units transfused was 57% (n ¼
218). The remaining 43% (n ¼ 165) were not trans-
fused. Of these, 38% (n ¼ 147) were reallocated and
5% (n ¼ 18) were discarded due to expiration.
The cost of each of the blood components per unit, at
the time of this study, was as follows:
Red blood cells (RBCs): £151.86
Fresh frozen plasma (FFP): £39.16
Platelets: £251.46
Cryoprecipitate: £219.66
From this information, we calculated the total cost of
the expired blood products. Wasted FFP totaled
£156.64; wasted RBCs, £2126.04. This illustrates the
ﬁnancial implication of blood wastage and reinforces
the usefulness of ECM to order blood on demand.DISCUSSION
Any procedure that can signiﬁcantly reduce blood
wastage and cost has clear beneﬁts for the patient, the
trust, and blood banks. There are many studies that
suggest the potential for safe and cost-effective blood
ordering by adopting the G&S method in place of the
routine cross-match if the C:T and TI indices indicate
cross-matched blood is not being transfused.6,24,25,28-30
However, no studies have reported on the proposed
effectiveness of ECM in head and neck surgery.
The results of this study show that the practice over-
ordered cross-matched blood for the excision of tumor
with neck dissection and free ﬂap procedure. The neck
dissection alone, excision of tumor and neck dissection,
and excision of tumor with neck dissection and pedicle
ﬂap procedures all had TI ﬁgures greater than 0.5 and
C:T ratios less than 2.5, indicating that blood trans-
fusion was required and the correct amount of blood
was ordered in all 4 procedures.These results contradict results published by Fordyce
et al. in 1998,28 which showed that for neck dissection
alone their C:T ratio was very high at 12.5 and their TI
score low at 0.21; therefore, those authors advised
a G&S policy for this procedure. This divergence in
results highlights that the MSBOS is a local tariff and
results are not transferrable to other units.31
The use of autologous blood and erythropoietin
preoperatively has been suggested by a number of authors
as another alternative to reduce wastage.18,20,23,31 This
has the beneﬁt of a potential reduction in the risk of
transmission of blood-borne viruses. Interest in these
methods has been heightened in light of conﬂicting
reports that allogeneic blood transfusions may increase
cancer recurrence and postoperative infection due to
immunomodulation.34 Despite the beneﬁt of avoiding
allogeneic blood, autologous transfusions may not be
suitable for use in maxillofacial oncology patients due to
the short time between the diagnosis and surgery, and the
expense of recombinant erythropoietin makes its use for
every patient impractical.20
Although the C:T and TI indices in the current study
are in line with the continued use of conventional cross-
match, the present study has shown that 43% of blood
cross-matched and reserved was not actually transfused
and 38% of the cross-matched blood was reallocated.
Reallocation of blood compromises its freshness for
transfusion. The effect of the duration of storage of
blood on morbidity has been debated, with evidence
presented on both sides.32 A large-scale clinical trial is
currently being performed in the United States to assess
the effect of the age of red cells on clinical outcomes
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duration of storage of blood affects treatment success.33
More pressing is the fact that of all the cross-matched
blood, 5% was discarded due to expiration. Avoiding
this wastage would have lessened the chances of
canceled surgical procedures due to shortages of
blood.28
To save blood and make better use of it, our results
suggest that ECM could be adopted in place of the
conventional cross-match with a preoperative G&S
policy for all patients. As blood was required for all 4
procedures in this study, the minimal amount of blood
required based on a local MSBOS could be ordered
using ECM in-theater at the start of the procedure.
Further blood could then be ordered on demand when
required. This protocol would have worked for the
patients screened in the current study, given that 82%
were eligible for ECM. Our results thus support the
conclusion of Walsh et al.,35 who reported that readily
available hospital transfusion support could eliminate
the need for preoperative conventional cross-matching.
However, there remains a need for further study of the
effect of ECM on blood conservation that compares
blood utilization, costs, and wastage before and after
ECM implementation.
CONCLUSION
This study has proposed that ECM for head and neck
surgical procedures could aid the reduction of blood
wastage and procedural costs. The authors recommend
the introduction of ECM for ordering blood for patients
undergoing elective major head and neck surgery,
because it is shown to be a safe and practical method for
verifying the compatibility of blood on demand.
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